Literature DB >> 9600817

Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR.

K Sotlar1, H C Selinka, M Menton, R Kandolf, B Bültmann.   

Abstract

Infections with high-risk human papillomaviruses (e.g., HPV-16) play an important role in the development of cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (IC). Continued expression of the viral E6 and E7 genes is believed to be a key factor for oncogenic transformation of infected cells. Two spliced transcripts of the E6/E7 oncogenes, termed E6*I and E6*II, can be detected by reverse transcriptase polymerase chain reaction (RT-PCR). To increase the sensitivity of detecting E6/E7 transcripts in cervical scrapes we took advantage of a nested RT-PCR (nRT-PCR) protocol. In a series of 30 HPV-16-positive patients with histologic diagnoses ranging from nondysplastic epithelium to IC, the application of nRT-PCR significantly improved the detection of E6/E7 transcripts compared to conventional RT-PCR. The prevalence of E6/E7 spliced transcripts correlated with lesion severity and the nRT-PCR protocol allowed detection of these transcripts even in nondysplastic epithelium and CIN I lesions. Therefore, in epidemiologic follow-up studies, detection of E6/E7 transcripts by nRT-PCR should prove to be a useful diagnostic tool for risk evaluations regarding the development of CIN and its progression to cervical cancer, especially in high-risk HPV-type-infected patients with CIN 0 and CIN I. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600817     DOI: 10.1006/gyno.1998.4994

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Authors:  Karl Sotlar; Luis Escribano; Olfert Landt; Stefanie Möhrle; Sonia Herrero; Antonio Torrelo; Ulrich Lass; Hans-Peter Horny; Burkhard Bültmann
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

3.  "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

Authors:  K Sotlar; W Saeger; F Stellmacher; J Stahmer; S Jäckle; P Valent; H-P Horny
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

4.  Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening.

Authors:  Laurence Lamarcq; James Deeds; David Ginzinger; Jean Perry; Siddhartha Padmanabha; Karen Smith-McCune
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

5.  Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

Authors:  K Sotlar; T Marafioti; H Griesser; J Theil; C Aepinus; R Jaussi; H Stein; P Valent; H P Horny
Journal:  Mol Pathol       Date:  2000-08

6.  HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Authors:  Dorota Pastuszak-Lewandoska; Anna Bartosińska-Dyc; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Daria Domańska; Krzysztof Szyłło; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2014-01-17       Impact factor: 3.064

7.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.

Authors:  Karl Sotlar; Anja Bache; Florian Stellmacher; Burkhard Bültmann; Peter Valent; Hans-Peter Horny
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

9.  Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.

Authors:  Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; Subhashini John; George Chandy
Journal:  Mol Diagn       Date:  2004

10.  Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

Authors:  Paola Cattani; Gian Franco Zannoni; Caterina Ricci; Sara D'Onghia; Ilaria Nausica Trivellizzi; Aldo Di Franco; Valerio G Vellone; Maria Durante; Giovanni Fadda; Giovanni Scambia; Giovanni Capelli; Rosa De Vincenzo
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.